Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery

Summary

Phase 2b trial evaluating the safety and efficacy of EGP-437, versus placebo using the EyeGate® II Drug Delivery System (EGDS) in patients having undergone cataract surgery with implantation of a monofocal posterior chamber intraocular lens (IOL).

Timeline

Start

2017-07-26

Primary completion

2017-11-07

Completion

2017-11-27

Drugs

Indications